The deal covers Sygnis' products for primer-free whole-genome amplification and its reverse transcriptase kits.
Labsco will be an exclusive sales agent partner for the FilmArray system in certain market segments in the US.
Having just wrapped up a key clinical trial of its first sepsis assay in around 200 ICU patients, the firm hopes to gain US marketing clearance by the end of this year.
GenomeWeb caught up with Ginocchio at the Clinical Virology Symposium this week in Daytona Beach, Fla.
The company's molecular diagnostic revenues grew more than 6 percent, driven by its human papillomavirus business, company officials said.
In Science this week: factors influencing retrotransposon integration sites, and more.
A bioethicist argues for the responsible use of germline gene editing.
Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.
Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.